Jim Cramer on Henry Schein: "I Think It's a Good Stock"

Henry Schein, Inc. (NASDAQ:HSIC) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business School students. During the lightning round, an HBS student asked if the private equity discipline can transform the company, and Cramer commented:

“They need to because you know, they charge too much, but they make a ton of money, and that last quarter was really good. I’ve gotta tell you, I was very surprised. Right into the opening bell yesterday. I looked through the numbers again. I think it’s a good stock. You’ve got a good one there.”

Henry Schein, Inc. (NASDAQ:HSIC) supplies healthcare products, equipment, and pharmaceuticals to dental and medical professionals. On November 5, Evercore ISI raised its price target on the stock to $90 from $83 while maintaining an Outperform rating. The analyst noted signs of stabilization in the dental market and that additional momentum is expected from a potential new CEO announcement in the fourth quarter.

While we acknowledge the potential of HSIC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.